Skip to main content
OICS v0.4.1 class · Healthcare

Commercial Biotech

ID CMB HC.PH.BIO.CMB

Research-led company whose approved medicines, new substances it discovered, in-licensed or acquired, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more. Approved new formulations of approved substances -> HC.PH.PHA.GNX.

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.BIO Biotechnology in the standard Biology-based drug developers.

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

Counted by primary class: every company classified here, including delisted companies and companies without filings.

Company Ticker Country Market cap Filings
UCB UCB Belgium $52.35Bas of 10 Jul 2026 2,006
Alnylam Pharmaceuticals, Inc. ALNY United States of America $41.76Bas of 11 Jul 2026 1,749
Revolution Medicines, Inc. RVMD United States of America $38.71Bas of 27 Jun 2026 911
BeOne Medicines Ltd. ONC United States of America $31.81Bas of 27 Mar 2026 3,317
Roivant Sciences Ltd. ROIV United States of America $26.48Bas of 11 Jul 2026 1,103
BioNTech SE BNTX Germany $23.13Bas of 20 Jul 2026 669
Moderna, Inc. MRNA United States of America $19.65Bas of 28 Mar 2026 1,687
INCYTE CORP INCY United States of America $19.62Bas of 22 Jun 2026 2,610
Genmab GMAB Denmark $16.88Bas of 6 Jul 2026 3,265
PharmaEssentia Corporation 6446 Taiwan $15.70Bas of 6 Jul 2026 2,835
Ascendis Pharma A/S ASND Denmark $15.60Bas of 24 Jun 2026 818
BridgeBio Pharma, Inc. BBIO United States of America $14.40Bas of 2 Apr 2026 906
Exelixis, Inc. EXEL United States of America $14.00Bas of 17 Jul 2026 2,475
Neurocrine Biosciences, Inc. NBIX United States of America $13.12Bas of 19 Mar 2026 2,193
Madrigal Pharmaceuticals, Inc. MDGL United States of America $12.37Bas of 13 Jul 2026 1,290
Axsome Therapeutics, Inc. AXSM United States of America $11.84Bas of 20 Jul 2026 781
CYTOKINETICS INC CYTK United States of America $11.57Bas of 2 Jul 2026 2,548
Krystal Biotech, Inc. KRYS United States of America $10.08Bas of 17 Jul 2026 574
Eisai Co., Ltd. 4523 Japan $9.65B 935
ImmunityBio, Inc. IBRX United States of America $9.17Bas of 1 Jul 2026 562
Corcept Therapeutics Incorporated CORT United States of America $9.10Bas of 27 Jun 2026 1,950
Verona Pharma plc Delisted VRNA United Kingdom $9.09Bas of 29 Jun 2026 860
Arrowhead Pharmaceuticals, Inc. ARWR United States of America $8.09Bas of 29 Mar 2026 1,374
Legend Biotech Corp LEGN United States of America $6.66Bas of 15 Jun 2026 432
Rhythm Pharmaceuticals, Inc. RYTM United States of America $5.93Bas of 8 Jun 2026 910
CRISPR Therapeutics AG CRSP Switzerland $5.79Bas of 9 Jul 2026 923
Mirum Pharmaceuticals, Inc. MIRM United States of America $5.77Bas of 8 Apr 2026 720
SK biopharmaceuticals Co., Ltd. 326030 South Korea $5.55Bas of 7 Apr 2026 522
TG Therapeutics, Inc. TGTX United States of America $5.35Bas of 5 Apr 2026 1,133
Apellis Pharmaceuticals, Inc. APLS United States of America $5.25Bas of 10 Jul 2026 1,284
Kiniksa Pharmaceuticals International, plc KNSA United States of America $4.55Bas of 25 Jun 2026 843
Amicus Therapeutics, Inc. FOLD United States of America $4.54Bas of 1 Apr 2026 2,125
Acadia Pharmaceuticals Inc. ACAD United States of America $4.49Bas of 13 Jul 2026 1,457
Celcuity Inc. CELC United States of America $4.31Bas of 8 Jun 2026 595
Travere Therapeutics, Inc. TVTX United States of America $4.26Bas of 7 Jun 2026 1,322
SANTEN PHARMACEUTICAL CO.,LTD. 4536 Japan $4.21B 684
Crinetics Pharmaceuticals, Inc. CRNX United States of America $3.91Bas of 12 Mar 2026 766
CATALYST PHARMACEUTICALS, INC. CPRX United States of America $3.85Bas of 8 Jul 2026 1,367
NewAmsterdam Pharma Co N.V. NAMS Netherlands $3.60Bas of 11 Mar 2026 461
Camurus CAMX Sweden $3.26Bas of 10 Jul 2026 487
Denali Therapeutics Inc. DNLI United States of America $2.87Bas of 31 Mar 2026 847
MorphoSys AG Delisted MOR Germany $2.81Bas of 1 Sep 2025 2,030
Tarsus Pharmaceuticals, Inc. TARS United States of America $2.65Bas of 11 Jun 2026 716
Ascentage Pharma Group International 6855 Hong Kong $2.62Bas of 7 Apr 2026 575
Agios Pharmaceuticals, Inc. AGIO United States of America $2.36Bas of 20 Jul 2026 1,365
BioCryst Pharmaceuticals, Inc. BCRX United States of America $2.26Bas of 4 Apr 2026 1,970
IOVANCE BIOTHERAPEUTICS, INC. IOVA United States of America $2.23Bas of 20 Jul 2026 1,003
Day One Biopharmaceuticals, Inc. Delisted DAWN United States of America $2.22Bas of 5 Apr 2026 505
Sarepta Therapeutics, Inc. SRPT United States of America $2.15Bas of 1 Apr 2026 1,543
Bavarian Nordic BAVA Denmark $2.05Bas of 20 Jul 2026 2,669

Companies in Biotechnology → Open in the screener →

Other names for this activity, and where neighboring activities go instead.

Also known as

No aliases listed.

Not here
Clinical-Stage Biotech CLB HC.PH.BIO.CLB

Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.

Also preclinical, drug developer

https://financialfilings.com/oics/CMB/

This page is keyed by the class ID CMB. IDs freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard